You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts

Last Updated: February 21, 2020

DrugPatentWatch Database Preview

Litigation Details for Bayer Schering Pharma AG v. Lupin Ltd. (S.D.N.Y. 2010)

Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

Bayer Schering Pharma AG v. Lupin Ltd. (S.D.N.Y. 2010)

Docket   Start Trial Date Filed 2010-07-15
Court District Court, S.D. New York Date Terminated 2010-12-08
Cause 35:271 Patent Infringement Assigned To Paul G. Gardephe
Jury Demand Plaintiff Referred To
Patents 5,569,652; 6,787,531; 6,933,395
Attorneys Adam K. Mortara; Amin S. Kassam; Bradford J. Badke; Jeanne C. Curtis; Joseph Vecchione DeMarco; Kate M. Lesciotto; Matthew A. Traupman; Matthew Raymond Ford; Paul J. Skiermont; Peter Benjamin Bensinger , Jr.; Robert Fritz Green; Salim A. Hasan; Sundeep K. Addy
Link to Docket External link to docket
Small Molecule Drugs cited in Bayer Schering Pharma AG v. Lupin Ltd.
The small molecule drugs covered by the patents cited in this case are   Start Trial ,   Start Trial , and   Start Trial .

Details for Bayer Schering Pharma AG v. Lupin Ltd. (S.D.N.Y. 2010)

Date Filed Document No. Description Snippet Link To Document
2010-09-27 10 of U.S. Patent No. 5,569,652. 35. Lupin admits that U.S. Patent No. 5,569,652 (“the ’652… 59. U.S. Patent Nos. 5,569,652 (“the ’652 patent”), 6,787,531 (“the ’531 patent”), and 6,933,395…COUNT ONE: CLAIM FOR PATENT INFRINGEMENT OF U.S. PATENT NO. 5,569,652 UNDER § 271(E)(2)…COUNT TWO: CLAIM FOR PATENT INFRINGEMENT OF U.S. PATENT NO. 5,569,652 UNDER § 271(B) …09/27/10 Page 9 of 20 respect to U.S. Patent Nos.: 5,569,652; 6,787,531; and 6,933,395, this certification External link to document
2010-12-08 22 Non-Liability and Covenant Not to Sue Regarding U.S. Patent No. 6,933,395. Document filed by Bayer Healthcare Pharmaceuticals…2010 8 December 2010 1:10-cv-05423 830 Patent Plaintiff District Court, S.D External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.